Evidence map›Paper›PMID 24130396›Full record

ArticleIndian journal of pharmacology

Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder.

Sai Krishna Tikka, Shobit Garg, Basudeb Das

Abstract readCase Reports
In one paragraph

Article in Indian journal of pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 8 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sai Krishna TikkaDepartment of Psychiatry, Central Institute of Psychiatry, Kanke, Ranchi, Jharkhand, India.
Shobit Garg
Basudeb Das
Central Institute of Psychiatry · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluvoxamine has a similar spectrum of adverse effects as compared to other selective serotonin reuptake inhibitors. However, fluvoxamine induced oculogyric dystonia is a rare instance in clinical practice. In this report, we present a case of obsessive compulsive disorder that developed oculogyric dystonia during the course of fluvoxamine mono-therapy and subsequently had a manic switch.

Indexed as

AdultAntidepressive Agents, Second-GenerationDystoniaEye MovementsFluvoxamineHumansMaleObsessive-Compulsive DisorderAntidepressive Agents, Second-GenerationFluvoxamineInduced manic switchoculogyric dystoniaselective serotonin reuptake inhibitor

Identifiers

PMID24130396
PMCPMC3793532
OpenAlexW2010784447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.